These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16313808)

  • 1. [The research on the relationship between the polymorphism of 1082A/G, anti-inflammatory interleukin-10 gene promoter with its effect of preventing ESRD patients from microinflammation and arteriosclerosis].
    Wu HC; Ling H; Na SP; Xie RJ
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2076-80. PubMed ID: 16313808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between a gene polymorphism of tumor necrosis factor-alpha (G/A) and end-stage renal disease: a pilot study from north India.
    Manchanda PK; Kumar A; Kaul A; Mittal RD
    Clin Chim Acta; 2006 Aug; 370(1-2):152-7. PubMed ID: 16545788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of non-HLA genetic variants in end-stage renal disease.
    Ranganath P; Tripathi G; Sharma RK; Sankhwar SN; Agrawal S
    Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism in patients with end-stage renal failure.
    Shu KH; Cheng CH; Wu MJ; Chen CH; Lee WC
    Ren Fail; 2005; 27(1):53-7. PubMed ID: 15717635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis.
    Buraczynska M; Jozwiak L; Ksiazek P; Borowicz E; Mierzicki P
    Transl Res; 2007 Aug; 150(2):101-5. PubMed ID: 17656329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the -2849 interleukin-10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritis.
    Lard LR; van Gaalen FA; Schonkeren JJ; Pieterman EJ; Stoeken G; Vos K; Nelissen RG; Westendorp RG; Hoeben RC; Breedveld FC; Toes RE; Huizinga TW
    Arthritis Rheum; 2003 Jul; 48(7):1841-8. PubMed ID: 12847677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the association of -667 aquaporin-2 (AQP-2) A/G promoter polymorphism with the incidence and clinical course of chronic kidney disease in Korea.
    Kang SW; Kim YW; Kim YH; Sohn HS; Joo H; Kim E
    Ren Fail; 2007; 29(6):693-8. PubMed ID: 17763164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine gene promoter polymorphisms and mortality in acute renal failure.
    Jaber BL; Rao M; Guo D; Balakrishnan VS; Perianayagam MC; Freeman RB; Pereira BJ
    Cytokine; 2004 Mar; 25(5):212-9. PubMed ID: 15036247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between oestrogen receptor alpha gene polymorphism and mortality in female end-stage renal disease patients.
    Kato S; Lindholm B; Axelsson J; Qureshi RA; Barany P; Heimbürger O; Gustafsson JA; Stenvinkel P; Nordfors L
    Nephrol Dial Transplant; 2007 Sep; 22(9):2571-7. PubMed ID: 17452407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-10 genotype protects end stage renal disease patients from microinflammation and arteriosclerosis.
    Wu HC; Ling H; Na SP; Xie RJ
    Chin Med J (Engl); 2005 Sep; 118(18):1549-51. PubMed ID: 16232332
    [No Abstract]   [Full Text] [Related]  

  • 12. An association study of inflammatory cytokine gene polymorphisms in Fabry disease.
    Safyan R; Whybra C; Beck M; Elstein D; Altarescu G
    Eur Cytokine Netw; 2006 Dec; 17(4):271-5. PubMed ID: 17353161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner.
    Tedde A; Laura Putignano A; Bagnoli S; Congregati C; Milla M; Sorbi S; Genuardi M; Papi L
    Scand J Gastroenterol; 2008; 43(6):712-8. PubMed ID: 18569989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 receptor antagonist gene polymorphism affects the progression of chronic renal failure.
    Buraczynska M; Ksiazek P; Kubit P; Zaluska W
    Cytokine; 2006 Nov; 36(3-4):167-72. PubMed ID: 17224277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effect of IL-10 and TGF-beta1 promoter polymorphisms as a risk factor for aspirin-intolerant asthma and rhinosinusitis.
    Kim SH; Yang EM; Lee HN; Cho BY; Ye YM; Park HS
    Allergy; 2009 Aug; 64(8):1221-5. PubMed ID: 19222424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease.
    Lio D; Licastro F; Scola L; Chiappelli M; Grimaldi LM; Crivello A; Colonna-Romano G; Candore G; Franceschi C; Caruso C
    Genes Immun; 2003 Apr; 4(3):234-8. PubMed ID: 12700599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients.
    Aker S; Bantis C; Reis P; Kuhr N; Schwandt C; Grabensee B; Heering P; Ivens K
    Nephrol Dial Transplant; 2009 Sep; 24(9):2847-51. PubMed ID: 19349293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of MDR1 gene polymorphism on progression of end-stage renal disease.
    Zhang WX; Chen B; Zhang W; Chen N; Yu ZC; Cai WM
    Acta Pharmacol Sin; 2007 Apr; 28(4):579-83. PubMed ID: 17376299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-10 and sudden infant death syndrome.
    Moscovis SM; Gordon AE; Al Madani OM; Gleeson M; Scott RJ; Roberts-Thomson J; Hall ST; Weir DM; Busuttil A; Blackwell CC
    FEMS Immunol Med Microbiol; 2004 Sep; 42(1):130-8. PubMed ID: 15325406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.